Compounds > cysteine

cysteine and Age-Related Macular Degeneration

cysteine has been researched along with Age-Related Macular Degeneration in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (23.08)18.2507
2000's7 (53.85)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonilha, VL1
Newsome, DA1
Brantley, MA; Cai, J; Li, C; Lu, P; Milne, GL; Osborn, MP; Rezaei, KA; Sanders, BJ; Sternberg, P2
Adkison, J; Bressler, S; Gensler, G; Jones, DP; Lynn, M; Moriarty-Craige, SE; Sternberg, P1
Jones, DP1
Bressler, S; Gensler, G; Ha, KN; Jones, DP; Lynn, M; Moriarty-Craige, SE; Sternberg, P1
Goicoechea de Jorge, E; Gomà, M; Montes, T; Pujol, O; Ramos, R; Rodríguez de Córdoba, S; Sánchez-Corral, P1
Arden, G; Bhattacharya, S; Eckstein, A; Fitzke, F; Inglehearn, C; Jay, M; Jubb, C; Keen, J; Wells, J; Wroblewski, J1
Amann, T; Felbor, U; Schönherr, U; Stöhr, H; Weber, BH1
Carrero-Valenzuela, RD; Klein, ML; Litt, M; Murphey, WH; Weleber, RG1
Ayuso, C; Bueno, J; Carballo, M; García-Sandoval, B; Giménez, A; Lorda, I; Martinez-Gimeno, M; Ramos, C; Trujillo, MJ1
Anand-Apte, B; Ebrahem, Q; Edwards, DR; Fox, PL; Qi, JH; Yeow, K1

Reviews

2 review(s) available for cysteine and Age-Related Macular Degeneration

ArticleYear
Oxidative Stress Regulation and DJ-1 Function in the Retinal Pigment Epithelium: Implications for AMD.
    Advances in experimental medicine and biology, 2018, Volume: 1074

    Topics: Animals; Cells, Cultured; Cysteine; Electron Transport Complex I; Free Radicals; Light; Macular Degeneration; Mice; Mice, Knockout; Models, Animal; Oxidation-Reduction; Oxidative Stress; Protein Deglycase DJ-1; Retinal Pigment Epithelium; Transcription, Genetic

2018
Extracellular redox state: refining the definition of oxidative stress in aging.
    Rejuvenation research, 2006,Summer, Volume: 9, Issue:2

    Topics: Aging; Cell Proliferation; Cysteine; Glutathione; Health Status; Humans; Macular Degeneration; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Smoking; Thioredoxins

2006

Trials

2 trial(s) available for cysteine and Age-Related Macular Degeneration

ArticleYear
A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration.
    Current eye research, 2008, Volume: 33, Issue:7

    Topics: Administration, Oral; Aged; Contrast Sensitivity; Cysteine; Double-Blind Method; Female; Humans; Macular Degeneration; Male; Prospective Studies; Retina; Vision, Ocular; Visual Acuity

2008
Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration.
    American journal of ophthalmology, 2007, Volume: 143, Issue:2

    Topics: Aged; Chromatography, High Pressure Liquid; Cysteine; Cystine; Dietary Supplements; Female; Glutathione; Glutathione Disulfide; Humans; Macular Degeneration; Male; Oxidation-Reduction; Zinc Oxide

2007

Other Studies

9 other study(ies) available for cysteine and Age-Related Macular Degeneration

ArticleYear
Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration.
    American journal of ophthalmology, 2012, Volume: 153, Issue:3

    Topics: Aged; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Complement Factor H; Cysteine; Cystine; Female; Furans; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glutathione; Humans; Isoprostanes; Lipid Peroxidation; Macular Degeneration; Male; Oxidative Stress; Polymorphism, Single Nucleotide; Prospective Studies; Proteins

2012
The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation.
    American journal of ophthalmology, 2012, Volume: 153, Issue:6

    Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Biomarkers; Copper; Cysteine; Cystine; Dietary Supplements; Female; Furans; Glutathione; Humans; Isoprostanes; Macular Degeneration; Male; Oxidative Stress; Pilot Projects; Prospective Studies; Vitamin E; Zinc Oxide

2012
Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration.
    American journal of ophthalmology, 2005, Volume: 140, Issue:6

    Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Chromatography, High Pressure Liquid; Copper; Cysteine; Cystine; Dietary Supplements; Female; Glutathione; Glutathione Disulfide; Humans; Macular Degeneration; Male; Oxidation-Reduction; Randomized Controlled Trials as Topic; Vitamin E; Zinc Oxide

2005
Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
    Molecular immunology, 2008, Volume: 45, Issue:10

    Topics: Amino Acid Substitution; Animals; Base Sequence; Blotting, Western; Chlorocebus aethiops; Complement Factor H; COS Cells; Cysteine; Eye; Genetic Predisposition to Disease; Glomerulonephritis, Membranoproliferative; Humans; Kidney; Macular Degeneration; Mass Spectrometry; Middle Aged; Molecular Sequence Data; Mutation; Recombinant Proteins; Tyrosine

2008
Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy.
    Nature genetics, 1993, Volume: 3, Issue:3

    Topics: Adult; Amino Acid Sequence; Arginine; Base Sequence; Cysteine; DNA; Exons; Eye Proteins; Female; Fluorescein Angiography; Genes, Dominant; Glutamine; Humans; Intermediate Filament Proteins; Macular Degeneration; Male; Membrane Glycoproteins; Molecular Sequence Data; Nerve Tissue Proteins; Oligodeoxyribonucleotides; Pedigree; Peripherins; Point Mutation; Polymerase Chain Reaction; Retinal Degeneration; Retinitis Pigmentosa; Sequence Deletion; Tryptophan

1993
A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.
    Human molecular genetics, 1995, Volume: 4, Issue:12

    Topics: Amino Acid Sequence; Base Sequence; Cysteine; DNA; Female; Humans; Macular Degeneration; Male; Molecular Sequence Data; Mutation; Pedigree; Proteins; Serine; Tissue Inhibitor of Metalloproteinase-3

1995
Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:6

    Topics: Adult; Aged; Chromosomes, Human, Pair 22; Cysteine; DNA; Female; Fundus Oculi; Humans; Macula Lutea; Macular Degeneration; Male; Microsatellite Repeats; Middle Aged; Pedigree; Point Mutation; Proteins; Serine; Tissue Inhibitor of Metalloproteinase-3

1996
Two novel mutations (Y141H; C214Y) and previously published mutation (R142W) in the RDS-peripherin gene in autosomal dominant macular dystrophies in Spanish families.
    Human mutation, 2001, Volume: 17, Issue:1

    Topics: Amino Acid Substitution; Arginine; Cysteine; Electrophoresis, Polyacrylamide Gel; Eye Proteins; Genes, Dominant; Histidine; Humans; Intermediate Filament Proteins; Macular Degeneration; Membrane Glycoproteins; Mutation, Missense; Nerve Tissue Proteins; Peripherins; Polymerase Chain Reaction; Retinal Degeneration; Tryptophan; Tyrosine

2001
Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
    The Journal of biological chemistry, 2002, Apr-19, Volume: 277, Issue:16

    Topics: Animals; Cell Adhesion; Cell Division; Cell Line; Cell Movement; Cells, Cultured; Chick Embryo; Collagen; Cysteine; Drug Combinations; Epithelial Cells; Genes, Dominant; Humans; Immunoblotting; Laminin; Macular Degeneration; Matrix Metalloproteinase Inhibitors; Mutation; Neovascularization, Physiologic; Phenotype; Pigment Epithelium of Eye; Proteoglycans; Retina; Serine; Tissue Inhibitor of Metalloproteinase-3; Transfection

2002